Role of the Microbiome, Probiotics, and ‘Dysbiosis Therapy’ in Critical Illness

Current Opinion in Critical Care - United States
doi 10.1097/mcc.0000000000000321
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy

Clinical Pharmacology and Therapeutics
Pharmacology
2016English

Microbiota and Allergy: From Dysbiosis to Probiotics

2012English

Gut Microbiome Dysbiosis and Honeybee Health

Journal of Applied Entomology
Insect ScienceAgronomyCrop Science
2011English

The Microbiome in Critical Illness: Firm Conclusions or Bact to Square One?

Digestive Diseases and Sciences
PhysiologyGastroenterology
2016English

Microbiome and Probiotics inHealth and HIV Infection

2017English

Glycemic Control and Insulin Therapy in Sepsis and Critical Illness

Jornal de Pediatria
Child HealthPediatricsPerinatology
2007English

Beneficial Effects of Probiotics for Infants and Children With Dysbiosis

2019English

Microbial Translocation and Microbiome Dysbiosis in HIV-associated Immune Activation

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2016English

Dysbiosis of Saliva Microbiome in Patients With Oral Lichen Planus

BMC Microbiology
Microbiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy